Perlow, H.K.; Khullar, K.; Kumar, R.; Sasmal, S.; Nakamoto, K.; Gokun, Y.; Eckstein, J.; Young, R.; Diaz, D.A.; Martin, D.;
et al. Evaluating the Impact of Common Non-Oncologic Medication Use During Radiotherapy in Patients with High-Risk Prostate Cancer. Curr. Oncol. 2025, 32, 353.
https://doi.org/10.3390/curroncol32060353
AMA Style
Perlow HK, Khullar K, Kumar R, Sasmal S, Nakamoto K, Gokun Y, Eckstein J, Young R, Diaz DA, Martin D,
et al. Evaluating the Impact of Common Non-Oncologic Medication Use During Radiotherapy in Patients with High-Risk Prostate Cancer. Current Oncology. 2025; 32(6):353.
https://doi.org/10.3390/curroncol32060353
Chicago/Turabian Style
Perlow, Haley K., Karishma Khullar, Ritesh Kumar, Sonya Sasmal, Kent Nakamoto, Yevgeniya Gokun, Jacob Eckstein, Rebekah Young, Dayssy A. Diaz, Douglas Martin,
and et al. 2025. "Evaluating the Impact of Common Non-Oncologic Medication Use During Radiotherapy in Patients with High-Risk Prostate Cancer" Current Oncology 32, no. 6: 353.
https://doi.org/10.3390/curroncol32060353
APA Style
Perlow, H. K., Khullar, K., Kumar, R., Sasmal, S., Nakamoto, K., Gokun, Y., Eckstein, J., Young, R., Diaz, D. A., Martin, D., Collier, K. A., Meng, L., Parikh, R. R., Clinton, S., & Wang, S.-J.
(2025). Evaluating the Impact of Common Non-Oncologic Medication Use During Radiotherapy in Patients with High-Risk Prostate Cancer. Current Oncology, 32(6), 353.
https://doi.org/10.3390/curroncol32060353
